Követés
Jessica A Bryant
Jessica A Bryant
Seres Therapeutics
E-mail megerősítve itt: mit.edu - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
Microbes on mountainsides: contrasting elevational patterns of bacterial and plant diversity
JA Bryant, C Lamanna, H Morlon, AJ Kerkhoff, BJ Enquist, JL Green
Proceedings of the National Academy of Sciences 105 (Supplement 1), 11505-11511, 2008
8442008
Diversity and Activity of Communities Inhabiting Plastic Debris in the North Pacific Gyre
JA Bryant, TM Clemente, DA Viviani, AA Fong, KA Thomas, P Kemp, ...
mSystems 1 (3), e00024-16, 2016
2672016
Spatial patterns of phylogenetic diversity
H Morlon, DW Schwilk, JA Bryant, PA Marquet, AG Rebelo, C Tauss, ...
Ecology letters 14 (2), 141-149, 2011
2082011
Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
EW Yu, L Gao, P Stastka, MC Cheney, J Mahabamunuge, M Torres Soto, ...
PLoS medicine 17 (3), e1003051, 2020
1602020
Detection and measurement of alternative splicing using splicing-sensitive microarrays
K Srinivasan, L Shiue, JD Hayes, R Centers, S Fitzwater, R Loewen, ...
Methods 37 (4), 345-359, 2005
1342005
Environmental drivers of a microbial genomic transition zone in the ocean's interior
DR Mende, JA Bryant, FO Aylward, JM Eppley, T Nielsen, ...
Nature Microbiology, https://www.nature.com/articles/s41564-0, 2017
1182017
Microbial community phylogenetic and trait diversity declines with depth in a marine oxygen minimum zone
JA Bryant, FJ Stewart, JM Eppley, EF DeLong
Ecology 93 (7), 1659-1673, 2012
1152012
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
P Feuerstadt, TJ Louie, B Lashner, EEL Wang, L Diao, JA Bryant, M Sims, ...
New England Journal of Medicine 386 (3), 220-229, 2022
762022
Community transcriptomics reveals universal patterns of protein sequence conservation in natural microbial communities
FJ Stewart, AK Sharma, JA Bryant, JM Eppley, EF DeLong
Genome Biol 12 (3), R26, 2011
712011
Wind and sunlight shape microbial diversity in surface waters of the North Pacific Subtropical Gyre
JA Bryant, FO Aylward, JM Eppley, DM Karl, MJ Church, EF DeLong
The ISME journal 10 (6), 1308-1322, 2016
692016
Distinct dissolved organic matter sources induce rapid transcriptional responses in coexisting populations of Prochlorococcus, Pelagibacter and the OM60 clade
AK Sharma, JW Becker, EA Ottesen, JA Bryant, S Duhamel, DM Karl, ...
Environmental microbiology 16 (9), 2815-2830, 2014
472014
Isolation and Characterization of Bacteria that Degrade Phosphonates in Marine Dissolved Organic Matter
OA Sosa, DJ Repeta, S Ferrón, JA Bryant, DR Mende, DM Karl, ...
Frontiers in Microbiology 8, 1786, 2017
362017
Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
C Normington, IB Moura, JA Bryant, DJ Ewin, EV Clark, MJ Kettle, ...
npj Biofilms and Microbiomes 7 (1), 1-10, 2021
292021
The biogeography of putative microbial antibiotic production
H Morlon, TK O'Connor, JA Bryant, LK Charkoudian, KM Docherty, ...
PloS one 10 (6), e0130659, 2015
182015
1503. Engraftment of Investigational Microbiome Drug, SER-262, in Subjects Receiving Vancomycin Is Associated with Reduced Rates of Recurrence after Primary Clostridium …
C Ford, K Litcofsky, B McGovern, D Pardi, R Nathan, V Hansen, ...
Open Forum Infectious Diseases 6 (Supplement_2), S547-S548, 2019
52019
1641. Treatment of Recurrent Clostridium difficile Infection With SER-109 Reduces Gastrointestinal Carriage of Antimicrobial Resistance Genes
C Ford, M Henn, J Bryant, L Diao, J Wortman, A Tomlinson, K Litcofsky, ...
Open Forum Infectious Diseases 5 (suppl_1), S46-S47, 2018
52018
RAPID CONVERSION OF PRIMARY TO SECONDARY BILE ACIDS IN SUBJECTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) FOLLOWING SER-109, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC
JA Bryant, L Diao, EJ O'Brien, CB Ford, KD Litcofsky, JR Wortman, ...
Gastroenterology 160 (6), S168-S168, 2021
22021
Compositions and methods for treating antibiotic resistance
CB Ford, J Bryant, EJ O'brien
22020
Engraftment of investigational microbiome therapeutic SER-109 is durable through 24 weeks in a randomized trial (ECOSPOR III) for the treatment of recurrent Clostridioides …
C Desjardins, JA Bryant, E Walsh, CB Ford, KD Litcofsky, JR Wortman, ...
GASTROENTEROLOGY 162 (7), S651-S651, 2022
12022
110: IMPACT OF SER-109, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC, ON STOOL FATTY ACID METABOLITES IN A PHASE 3 RANDOMIZED TRIAL (ECOSPOR III) FOR TREATMENT OF RECURRENT …
JA Bryant, M Vulic, C Desjardins, CB Ford, KD Litcofsky, JR Wortman, ...
Gastroenterology 162 (7), S-21, 2022
12022
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20